Skip to main content
. 2019 Jan 18;34(2):231–240. doi: 10.1002/jbmr.3603

Figure 3.

Figure 3

Associations between RXRA methylation at CpG 5, CpG 11, and CpG 12 and whole‐body minus head bone area (cm2), bone mineral content (g), BMD (g/cm2), adjusted for sex, by treatment group (placebo [red bars] or 1000 IU cholecalciferol daily [blue bars]). Outcomes expressed per 10% increase in methylation.